ALKERMES | Satış Brüt Kar





Satış Brüt Kar Değişiklik Tarih
AbbVie USD 10.47B 605M 2025-09
Acadia Pharmaceuticals USD 256.99M 13.15M 2025-09
ALKERMES USD 265.83M 8.06M 2025-09
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 4.95M 15.34M 2025-03
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 6.2B 620M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Ionis Pharmaceuticals USD 155M 293M 2025-09
J&J USD 16.6B 118M 2025-12
Merck USD 13.42B 431M 2025-09
Minerva Neurosciences -4.27M 26.79M 2024-12
Nektar Therapeutics USD 13.75M 650K 2024-06
Neurocrine Biosciences USD 780.9M 104.7M 2025-09
Otsuka Holdings JPY 429.15B 2.96B 2025-06
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09


ALKERMES Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.